These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28693096)

  • 1. Chiral penicillamine-modified selenium nanoparticles enantioselectively inhibit metal-induced amyloid β aggregation for treating Alzheimer's disease.
    Sun D; Zhang W; Yu Q; Chen X; Xu M; Zhou Y; Liu J
    J Colloid Interface Sci; 2017 Nov; 505():1001-1010. PubMed ID: 28693096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-β aggregation and cytotoxicity.
    Zhang J; Zhou X; Yu Q; Yang L; Sun D; Zhou Y; Liu J
    ACS Appl Mater Interfaces; 2014 Jun; 6(11):8475-87. PubMed ID: 24758520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-Induced Chiral Iron Copper Selenide Nanoparticles Prevent β-Amyloidopathy In Vivo.
    Zhang H; Hao C; Qu A; Sun M; Xu L; Xu C; Kuang H
    Angew Chem Int Ed Engl; 2020 Apr; 59(18):7131-7138. PubMed ID: 32067302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
    Huo X; Zhang Y; Jin X; Li Y; Zhang L
    J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer's disease.
    Sun D; Li N; Zhang W; Zhao Z; Mou Z; Huang D; Liu J; Wang W
    Colloids Surf B Biointerfaces; 2016 Dec; 148():116-129. PubMed ID: 27591943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral metallohelical complexes enantioselectively target amyloid β for treating Alzheimer's disease.
    Li M; Howson SE; Dong K; Gao N; Ren J; Scott P; Qu X
    J Am Chem Soc; 2014 Aug; 136(33):11655-63. PubMed ID: 25062433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gold nanoparticle-capped mesoporous silica-based H
    Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
    Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer's disease.
    Hou K; Zhao J; Wang H; Li B; Li K; Shi X; Wan K; Ai J; Lv J; Wang D; Huang Q; Wang H; Cao Q; Liu S; Tang Z
    Nat Commun; 2020 Sep; 11(1):4790. PubMed ID: 32963242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid β-protein fibrillation and cytotoxicity.
    Xiong N; Dong XY; Zheng J; Liu FF; Sun Y
    ACS Appl Mater Interfaces; 2015 Mar; 7(10):5650-62. PubMed ID: 25700145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro evaluation of multi-target-directed selenium-chondroitin sulfate nanoparticles in protecting against the Alzheimer's disease.
    Gao F; Zhao J; Liu P; Ji D; Zhang L; Zhang M; Li Y; Xiao Y
    Int J Biol Macromol; 2020 Jan; 142():265-276. PubMed ID: 31593732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyrinic Metal-Organic Framework PCN-224 Nanoparticles for Near-Infrared-Induced Attenuation of Aggregation and Neurotoxicity of Alzheimer's Amyloid-β Peptide.
    Wang J; Fan Y; Tan Y; Zhao X; Zhang Y; Cheng C; Yang M
    ACS Appl Mater Interfaces; 2018 Oct; 10(43):36615-36621. PubMed ID: 30338980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of biogenic selenium nanoparticles against Leishmania major: in vitro and in vivo studies.
    Beheshti N; Soflaei S; Shakibaie M; Yazdi MH; Ghaffarifar F; Dalimi A; Shahverdi AR
    J Trace Elem Med Biol; 2013 Jul; 27(3):203-7. PubMed ID: 23219368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiral Metallo-Supramolecular Complex Directed Enantioselective Self-Assembly of β-Sheet Breaker Peptide for Amyloid Inhibition.
    Li M; Zhao C; Ren J; Qu X
    Small; 2015 Sep; 11(36):4651-5. PubMed ID: 26136296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuning the interactions between chiral plasmonic films and living cells.
    Zhao X; Xu L; Sun M; Ma W; Wu X; Xu C; Kuang H
    Nat Commun; 2017 Dec; 8(1):2007. PubMed ID: 29222410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-dependent structural change of D-penicillamine-capped chiral gold nanoparticles investigated by infrared spectroscopy.
    Ock KS; Dembereldorj U; Park J; Ganbold EO; Kim S; Shin HC; Joo SW
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Feb; 102():419-24. PubMed ID: 23261512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Se/Ru nanoparticles as inhibitors of metal-induced Aβ aggregation in Alzheimer's disease.
    Yang L; Chen Q; Liu Y; Zhang J; Sun D; Zhou Y; Liu J
    J Mater Chem B; 2014 Apr; 2(14):1977-1987. PubMed ID: 32261634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid β aggregation and reactive oxygen species formation properties.
    Yang L; Wang W; Chen J; Wang N; Zheng G
    J Biomed Mater Res A; 2018 Dec; 106(12):3034-3041. PubMed ID: 30295993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal Delivery of D-Penicillamine Hydrogel Upregulates a Disintegrin and Metalloprotease 10 Expression via Melatonin Receptor 1 in Alzheimer's Disease Models.
    Zhong M; Kou H; Zhao P; Zheng W; Xu H; Zhang X; Lan W; Guo C; Wang T; Guo F; Wang Z; Gao H
    Front Aging Neurosci; 2021; 13():660249. PubMed ID: 33935689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.